News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
376,292 Results
Type
Article (14738)
Company Profile (115)
Press Release (361434)
Multimedia
Podcasts (50)
Webinars (9)
Section
Business (112782)
Career Advice (457)
Deals (18657)
Drug Delivery (41)
Drug Development (31257)
Employer Resources (51)
FDA (8837)
Job Trends (7696)
News (173039)
Policy (12397)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (1332)
Accelerated approval (10)
Allergies (71)
Alliances (34933)
ALS (42)
Alzheimer's disease (628)
Antibody-drug conjugate (ADC) (179)
Approvals (9041)
Artificial intelligence (444)
Autoimmune disease (61)
Automation (31)
Bankruptcy (131)
Best Places to Work (6520)
BIOSECURE Act (7)
Biosimilars (31)
Biotechnology (85)
Bladder cancer (62)
Brain cancer (27)
Breast cancer (262)
Cancer (2189)
Cardiovascular disease (149)
Career advice (416)
Career pathing (9)
CAR-T (200)
CDC (8)
Cell therapy (489)
Cervical cancer (21)
Clinical research (25870)
Collaboration (1231)
Compensation (230)
Complete response letters (8)
COVID-19 (1223)
CRISPR (85)
C-suite (481)
Cystic fibrosis (60)
Data (2637)
Decentralized trials (1)
Denatured (26)
Depression (43)
Diabetes (211)
Diagnostics (5145)
Digital health (36)
Diversity (7)
Diversity, equity & inclusion (9)
Drug discovery (163)
Drug pricing (19)
Drug shortages (4)
Duchenne muscular dystrophy (86)
Earnings (40524)
Editorial (9)
Employer branding (8)
Employer resources (45)
Events (53410)
Executive appointments (549)
FDA (10441)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (5)
Frontotemporal dementia (8)
Funding (897)
Gene editing (171)
Generative AI (38)
Gene therapy (345)
GLP-1 (302)
Government (1278)
Grass and pollen (3)
Guidances (220)
Healthcare (9917)
HIV (23)
Huntington's disease (13)
IgA nephropathy (26)
Immunology and inflammation (68)
Immuno-oncology (19)
Indications (50)
Infectious disease (1364)
Inflammatory bowel disease (81)
Inflation Reduction Act (5)
Influenza (73)
Intellectual property (151)
Interviews (52)
IPO (8060)
IRA (10)
Job creations (1438)
Job search strategy (363)
JPM (20)
Kidney cancer (6)
Labor market (24)
Layoffs (131)
Leadership (7)
Legal (2534)
Liver cancer (43)
Longevity (6)
Lung cancer (245)
Lymphoma (171)
Machine learning (34)
Management (18)
Manufacturing (524)
MASH (36)
Medical device (11842)
Medtech (11891)
Mergers & acquisitions (11231)
Metabolic disorders (399)
Multiple sclerosis (62)
NASH (3)
Neurodegenerative disease (120)
Neuropsychiatric disorders (19)
Neuroscience (1082)
NextGen: Class of 2026 (3537)
Non-profit (1533)
Now hiring (15)
Obesity (139)
Opinion (97)
Ovarian cancer (92)
Pain (105)
Pancreatic cancer (101)
Parkinson's disease (118)
Partnered (20)
Patents (301)
Patient recruitment (243)
Peanut (31)
People (33675)
Pharmaceutical (18)
Pharmacy benefit managers (3)
Phase 1 (9519)
Phase 2 (11616)
Phase 3 (7552)
Pipeline (2546)
Policy (59)
Postmarket research (502)
Preclinical (4282)
Press Release (66)
Prostate cancer (96)
Psychedelics (6)
Radiopharmaceuticals (177)
Rare diseases (299)
Real estate (3398)
Recruiting (22)
Regulatory (10374)
Reports (20)
Research institute (1300)
Resumes & cover letters (69)
Rett syndrome (21)
RNA editing (9)
RSV (40)
Schizophrenia (32)
Series A (162)
Series B (109)
Service/supplier (6)
Sickle cell disease (32)
Special edition (1)
Spinal muscular atrophy (60)
Sponsored (20)
Startups (2528)
State (2)
Stomach cancer (2)
Supply chain (48)
Tariffs (10)
The Weekly (23)
Vaccines (496)
Venture capital (43)
Weight loss (49)
Women's health (45)
Worklife (2)
Date
Last 7 days (274)
Last 30 days (1063)
Last 365 days (14647)
2026 (1396)
2025 (15031)
2024 (18706)
2023 (22097)
2022 (30813)
2021 (32513)
2020 (30537)
2019 (25793)
2018 (19458)
2017 (18871)
2016 (17761)
2015 (20560)
2014 (15177)
2013 (12742)
2012 (13781)
2011 (14067)
2010 (12826)
Location
Africa (325)
Alabama (69)
Alaska (6)
Arizona (178)
Arkansas (10)
Asia (24892)
Australia (4315)
California (5290)
Canada (1668)
China (547)
Colorado (284)
Connecticut (235)
Delaware (107)
Europe (50934)
Florida (906)
Georgia (219)
Hawaii (2)
Idaho (33)
Illinois (471)
India (33)
Indiana (263)
Iowa (8)
Japan (271)
Kansas (101)
Kentucky (15)
Louisiana (18)
Maine (22)
Maryland (718)
Massachusetts (3540)
Michigan (274)
Minnesota (407)
Mississippi (4)
Missouri (98)
Montana (27)
Nebraska (15)
Nevada (51)
New Hampshire (83)
New Jersey (1561)
New Mexico (18)
New York (1418)
North Carolina (758)
North Dakota (9)
Northern California (2241)
Ohio (169)
Oklahoma (16)
Oregon (24)
Pennsylvania (1010)
Puerto Rico (19)
Rhode Island (34)
South America (512)
South Carolina (60)
South Dakota (1)
Southern California (2267)
Tennessee (103)
Texas (876)
United States (19712)
Utah (193)
Vermont (1)
Virginia (90)
Washington D.C. (18)
Washington State (502)
West Virginia (3)
Wisconsin (87)
Wyoming (1)
376,292 Results for "dilon technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Dilon Technologies Announces FDA Approval and U.S. Launch of MarginProbe® 2, Next-Generation Intraoperative margin assessment technology
December 16, 2025
·
3 min read
Press Releases
Dilon Technologies, Inc. Closes $9 Million in Growth Capital Financing
June 9, 2025
·
2 min read
BioCapital
Dilon Technologies Announces the Beginning of Enrollment in its Pivotal Trial of the Next Generation MarginProbe™ 2 Used in Real-Time Margin Assessment
Dilon Technologies Inc. announced today the enrollment of its first patient in the Prospective, Single-Arm, Multi-Center Pivotal Trial for its next generation MarginProbe™ 2 product used in real-time margin assessment.
February 5, 2024
·
2 min read
BioCapital
Dilon Technologies Announces the Publication of Data Demonstrating Cost-Savings Results from the Use of MarginProbeTM Compared to a Full Cavity Shave (FCS) Approach
Dilon Technologies Inc. announced today the publication of Cost Minimization in Breast Conserving Surgery: A Comparative Study of Radiofrequency Spectroscopy and Full Cavity Shave Margins for Patients Undergoing Breast Conserving Surgery, in the Journal of Cost Effectiveness and Resource Allocation.
September 22, 2023
·
2 min read
Genetown
Dilon Technologies Selects AcuityMD Platform to Accelerate its Preventative Breast Cancer Surgery Devices to More Oncologists
AcuityMD, providers of a novel commercial platform for medical technology (MedTech) companies, has signed a multi-year contract with Dilon Technologies, a global leader in devices for breast cancer treatment and diagnosis.
April 4, 2023
·
4 min read
Regulatory
6 Biotechs With a Shot at the FDA’s Platform Technology Designation
After revoking Sarepta’s award in July and awarding one to Krystal last month, the FDA’s platform technology designation program appears to be back on track. These six biotechs could be on the regulator’s radar.
November 21, 2025
·
9 min read
·
Tristan Manalac
Deals
SmartBreast™ Acquires Molecular Breast Imaging Assets from Dilon Technologies®
Smart Breast Corporation (SmartBreast™), a privately held company focused on breast cancer screening and detection, announced today that it has acquired certain Molecular Breast Imaging (MBI) assets from Dilon Technologies, Inc. (Dilon) for an undisclosed amount. The acquired MBI technology sees through dense breast tissue to fi
December 29, 2020
·
3 min read
Press Releases
Zelluna promotes Emilie Gauthy to Chief Technology Officer
February 3, 2026
·
2 min read
Press Releases
Avant Technologies Highlights the Critical Role of Cell Encapsulation Technology in Revolutionizing Diabetes Treatment
December 17, 2025
·
5 min read
Press Releases
Artis BioSolutions Announces Agreement to Acquire Syngoi Technologies to Deliver Next Generation Solutions for Synthetic DNA Technology
January 6, 2026
·
4 min read
1 of 37,630
Next
